Our visual memory system has a phenomenally large capacity. Flick through the image gallery on your phone, or fast forward through a previously watched movie, and notice how the briefly presented images trigger memories with ...
Sep 21, 2021
0
0
How should diagnostic tests developed in laboratories in hospitals and other health care settings be regulated—if at all? That's a question that has stirred lively debate within the U.S. health care system for years, but ...
Sep 16, 2021
0
12
A group of researchers including a Concordia Ph.D. student have developed a new method of bioprinting adult neuron cells. They're using a new laser-assisted technology that maintains high levels of cell viability and functionality.
Sep 15, 2021
0
112
Epilepsy is one of the most common chronic neurological diseases, affecting more than 50 million people worldwide. Although it is believed that a large proportion of childhood-onset epilepsies are caused by genetic changes, ...
Aug 31, 2021
0
296
Human induced pluripotent stem cells (iPSCs) can be used to generate brain organoids containing an eye structure called the optic cup, according to a study published August 17 in the journal Cell Stem Cell. The organoids ...
Aug 17, 2021
1
1059
People taking certain drugs to lower blood sugar for type 2 diabetes had less amyloid in the brain, a biomarker of Alzheimer's disease, when compared to both people with type 2 diabetes not taking the drugs and people without ...
Aug 11, 2021
0
67
When the COVID-19 pandemic ripped through New England and the rest of the United States in early 2020, substance use disorder treatment centers were forced to make massive changes to minimize the spread of coronavirus.
Jul 21, 2021
0
4
Emergency departments and inpatient medical personnel rarely conducted HIV testing on intravenous drug users in a West Virginia county with one of the nation's highest spikes in such cases, according to a federal investigation ...
Jun 25, 2021
0
3
Scientists have identified a new class of targeted cancer drugs that offer the potential to treat patients whose tumors have faulty copies of the BRCA cancer genes.
Jun 17, 2021
0
24
In a highly anticipated announcement, the U.S. Food and Drug Administration on Monday, June 7, approved the first new drug for Alzheimer's disease in nearly two decades.
Jun 15, 2021
0
2
